Japanese journal of clinical oncologyAged80 and overFemaleHumansMale
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortium.
Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, Kensuke Bekku, Keita Kobayashi, Nakanori Fujii, Kenichi Nishimura, Noriyoshi Miura, Yoichiro Tohi, Takuma Kato, Shinkuro Yamamoto, Hideo Fukuhara, Atsushi Takamoto, Ryutaro Shimizu, Shuichi Morizane
Published: 202610.1093/jjco/hyaf163
Abstract
PURPOSE: Despite 4-6 cycles of first-line chemotherapy being recommended before the initiation of avelumab maintenance treatment, a non-negligible number of patients received <4 cycles of first-line chemotherapy due to adverse events or pre-existing…
Preview only. Read the full abstract at the source